SEATTLE-- (BUSINESS WIRE)--NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the availability ...
German and U.S.-based molecular diagnostics firm Epigenomics got FDA approval for its blood-based colorectal cancer screening test. Epigenomics' Epi proColon uses a blood sample to see whether or not ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively ...
NanoString Technologies ($NSTG) is teaming up with Brigham and Women's Hospital (BWH) to study genomic biomarkers and develop diagnostic tests for cancer, furthering ...
NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join ...
Medivation and NanoString Technologies have entered into a collaboration worth up to $22 million with Astellas Pharma to pursue a gene expression signature algorithm from Medivation and create a ...
NanoString Technologies, Inc. NSTG recently made significant strides in its translational research business. The company entered into CosMxSpatial Molecular Imager partnerships with three specialty ...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment ...
Life science tools for discovery and translational research provider, NanoString Technologies (NASDAQ:NSTG) entered into three new contract research organization CosMx Spatial Molecular Imager ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback